A tooth whitening kit and method of whitening teeth using the same. The method may include applying a tooth whitening composition directly to surfaces of a user's teeth, exposing the surfaces of the user's teeth to ambient air for a first period of time to form a film of the tooth whitening composition on the surfaces of the user's teeth, applying light to the surfaces of the user's teeth for a second period of time while the film of the tooth whitening composition remains on the surfaces of the user's teeth, ceasing application of the light to the surfaces of the user's teeth and leaving the film of the tooth whitening composition on the surfaces of the user's teeth for a third period of time, and removing the film of the tooth whitening composition from the surfaces of the user's teeth.

Systems and techniques for configuring a light therapy oral guard include receiving sensed data from a first sensor associated with the light therapy oral guard, providing the sensed data from the first sensor to a machine learning model, receiving a machine learning output from the machine learning model based on the sensed data from the first sensor, the machine learning output comprising a light therapy oral guard configuration, and configuring the light therapy oral guard based on the light therapy oral guard configuration.

The present invention provides for devices and methods of treating wounds, including general wounds, gum disease and gingival tissues post scaling/root planning, using a diode laser which generates a beam of light having a wavelength in the visible portion of the electromagnetic spectrum (400 nm-700 nm). Further disclosed are devices and methods capable of stimulating tissue regeneration at the site of a wound.

The present invention relates generally to systems, devices, and methods for tracking compliance of orthodontic appliance usage, and more specifically to systems, devices, and methods for tracking compliance of orthodontic appliance usage using a compliance device and/or a light therapy apparatus. The invention provides compliances device that can be configured to be disposed within a patient's mouth. In some embodiments, the compliance device can comprise a sensor configured to detect an input associated with whether an orthodontic appliance is at least partially disposed within the patient's mouth at a first time and at a second time, with the second time being subsequent to the first time.

A computer-based system for receiving, analyzing, processing, managing and sending personal health information, and other information in conjunction with use of one or more personal nebulizer or vaporizing devices and personal breath analysis devices. System devices include a personal nebulizer or vaporizing unit with a mouthpiece, which may be detachable and replaceable. The mouthpiece includes an orifice through which vapor is emitted. The substance to be vaporized is contained in an ampoule inserted into the device, where the substance enters an atomization chamber where vaporization is achieved through piezoelectric transducers or atomizers providing sonic or ultrasonic vibration. The substance includes a variety of therapeutic, homeopathic, or naturopathic formulations, remedies, or serums.

This disclosure relates to various systems and methods related to preventative laser-based treatment of a dental tissue; for example, to prevent a patient from forming cavities. In some instances, a laser-based treatment system can generate a laser beam pulse with a fluence profile at a treatment site that results in either an increase in acid resistance of the tissue or removal of carbonate from the tissue, without melting or ablating the tissue. In some instances, the laser-based treatment system can direct the laser beam to various locations within a treatment site according to a temporal and/or spatial pattern, that results in either an increase in acid resistance of the tissue or removal of carbonate from the tissue, without melting or ablating the tissue. Many other systems and techniques for preventative and other laser-based treatment are also described.

An illumination system for a medical technology therapy and/or diagnosis system is provided. The system includes a light source, an optical waveguide, and an optical element in the form of a diffuser element. The optical waveguide has a first end that is connectable or assignable to the light source and the diffuser element is arranged at a second end of the optical waveguide so that light from the optical waveguide is injected into the optical element. The optical element has a lateral surface covered by a reflector layer at least in a section thereof. The reflector layer includes a mirror layer. The optical element has a light-reflecting area covered by the reflector layer and a light-transmissive area that is free of the reflector layer. Thus, light injected into the optical element is reflected on the light-reflecting area and emitted from the light-transmissive area.

An oral treatment device that emits light onto surfaces of a user's teeth. In one aspect, the oral treatment device includes an intraoral mouthpiece. The mouthpiece comprises a lamp support structure comprising a lamp support surface and is formed of a first material. A flexible lamp is mounted to the lamp support surface so that a light emitting surface of the flexible lamp assumes a concave curvature, thereby forming a lamp assembly. A guard component is overmolded to the lamp assembly. In one embodiment, the oral treatment device may be a teeth whitening device.

An aqueous solution for intraoral cleaning via irradiation with ultraviolet ray and/or near-ultraviolet visible ray and/or ray in an 800-900 nm near-infrared region is employed as the hydrogen peroxide aqueous solution, wherein a concentration of hydrogen peroxide is 1 w/v % to 7 w/v %, and a concentration of a hydrogen peroxide stabilizer is 81 ppm (mg/L) or less in the aqueous solution.

The present invention provides methods for treating, reducing the severity, or inhibiting the growth of cancer (e.g., skin cancer). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a programmed death 1 (PD-1) antagonist (e.g., an anti-PD-1 antibody). In certain embodiments, the skin cancer is cutaneous squamous cell carcinoma or basal cell carcinoma.